Ident. | Authors (with country if any) | Title |
---|
000659 (2020) |
Natalie M. Linton ; Tetsuro Kobayashi ; Yichi Yang ; Katsuma Hayashi ; Andrei R. Akhmetzhanov ; Sung-Mok Jung ; Baoyin Yuan ; Ryo Kinoshita ; Hiroshi Nishiura [Japon] | Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data |
000706 (2020) |
Shweta Saraswat ; Meenakshi Chaudhary ; Deepak Sehgal | Hepatitis E Virus Cysteine Protease Has Papain Like Properties Validated by in silico Modeling and Cell-Free Inhibition Assays |
000721 (2020) |
Maged N. Kamel Boulos ; Estella M. Geraghty [États-Unis] | Geographical tracking and mapping of coronavirus disease COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around the world: how 21st century GIS technologies are supporting the global fight against outbreaks and epidemics |
000722 (2020) |
Carmine Ceraolo [Italie] ; Federico M. Giorgi [Italie] | Genomic variance of the 2019-nCoV coronavirus. |
000784 (2020) |
Jing-Wen Ai [République populaire de Chine] ; Yi Zhang [République populaire de Chine] ; Hao-Cheng Zhang [République populaire de Chine] ; Teng Xu [République populaire de Chine] ; Wen-Hong Zhang [République populaire de Chine] | Era of molecular diagnosis for pathogen identification of unexplained pneumonia, lessons to be learned. |
000790 (2020) |
Nanshan Chen [République populaire de Chine] ; Min Zhou [République populaire de Chine] ; Xuan Dong [République populaire de Chine] ; Jieming Qu [République populaire de Chine] ; Fengyun Gong [République populaire de Chine] ; Yang Han [République populaire de Chine] ; Yang Qiu [République populaire de Chine] ; Jingli Wang [République populaire de Chine] ; Ying Liu [République populaire de Chine] ; Yuan Wei [République populaire de Chine] ; Jia'An Xia [République populaire de Chine] ; Ting Yu [République populaire de Chine] ; Xinxin Zhang [République populaire de Chine] ; Li Zhang [République populaire de Chine] | Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. |
000799 (2020) |
Shan-Lu Liu [États-Unis] ; Linda Saif [États-Unis] | Emerging Viruses without Borders: The Wuhan Coronavirus. |
000807 (2020) |
Yi-Hong Zhou [République populaire de Chine] ; Yuan-Yuan Qin [République populaire de Chine] ; Yan-Qiu Lu [République populaire de Chine] ; Feng Sun [République populaire de Chine] ; Sen Yang [République populaire de Chine] ; Vijay Harypursat [République populaire de Chine] ; Sheng-Quan Tang [République populaire de Chine] ; Yin-Qiu Huang [République populaire de Chine] ; Xiao-Qing He [République populaire de Chine] ; Yan-Ming Zeng [République populaire de Chine] ; Yao Li [République populaire de Chine] ; Xiao-Lei Xu [République populaire de Chine] ; Ting Zhao [République populaire de Chine] ; Yao-Kai Chen [République populaire de Chine] | Effectiveness of glucocorticoid therapy in patients with severe novel coronavirus pneumonia: protocol of a randomized controlled trial. |
000823 (2020) |
Chuan Qin [République populaire de Chine] ; Luoqi Zhou [République populaire de Chine] ; Ziwei Hu [République populaire de Chine] ; Shuoqi Zhang [République populaire de Chine] ; Sheng Yang [République populaire de Chine] ; Yu Tao [République populaire de Chine] ; Cuihong Xie [République populaire de Chine] ; Ke Ma [République populaire de Chine] ; Ke Shang [République populaire de Chine] ; Wei Wang [République populaire de Chine] ; Dai-Shi Tian [République populaire de Chine] | Dysregulation of immune response in patients with COVID-19 in Wuhan, China. |
000834 (2020) |
Liying Dong [République populaire de Chine] ; Shasha Hu [République populaire de Chine] ; Jianjun Gao [République populaire de Chine] | Discovering drugs to treat coronavirus disease 2019 (COVID-19). |
000843 (2020) |
Joungha Won [Corée du Sud] ; Solji Lee [Corée du Sud] ; Myungsun Park [Corée du Sud] ; Tai Young Kim [Corée du Sud] ; Mingu Gordon Park [Corée du Sud] ; Byung Yoon Choi [Corée du Sud] ; Dongwan Kim [Corée du Sud] ; Hyeshik Chang [Corée du Sud] ; V Narry Kim [Corée du Sud] ; C Justin Lee [Corée du Sud] | Development of a Laboratory-safe and Low-cost Detection Protocol for SARS-CoV-2 of the Coronavirus Disease 2019 (COVID-19). |
000968 (2020) |
Soheil Kooraki [États-Unis] ; Melina Hosseiny [États-Unis] ; Lee Myers [États-Unis] ; Ali Gholamrezanezhad [États-Unis] | Coronavirus (COVID-19) Outbreak: What the Department of Radiology Should Know. |
000A31 (2020) |
Wei-Jie Guan ; Zheng-Yi Ni ; Yu Hu ; Wen-Hua Liang ; Chun-Quan Ou ; Jian-Xing He ; Lei Liu ; Hong Shan ; Chun-Liang Lei ; David S C. Hui ; Bin Du ; Lan-Juan Li ; Guang Zeng ; Kwok-Yung Yuen ; Ru-Chong Chen ; Chun-Li Tang ; Tao Wang ; Ping-Yan Chen ; Jie Xiang ; Shi-Yue Li ; Jin-Lin Wang ; Zi-Jing Liang ; Yi-Xiang Peng ; Li Wei ; Yong Liu ; Ya-Hua Hu ; Peng Peng ; Jian-Ming Wang ; Ji-Yang Liu ; Zhong Chen ; Gang Li ; Zhi-Jian Zheng ; Shao-Qin Qiu ; Jie Luo ; Chang-Jiang Ye ; Shao-Yong Zhu ; Nan-Shan Zhong | Clinical Characteristics of Coronavirus Disease 2019 in China. |
000A32 (2020) |
Fang Zheng [République populaire de Chine] ; Chun Liao [République populaire de Chine] ; Qi-Hong Fan [République populaire de Chine] ; Hong-Bo Chen [République populaire de Chine] ; Xue-Gong Zhao [République populaire de Chine] ; Zhong-Guo Xie [République populaire de Chine] ; Xi-Lin Li [République populaire de Chine] ; Chun-Xi Chen [République populaire de Chine] ; Xiao-Xia Lu [République populaire de Chine] ; Zhi-Sheng Liu [République populaire de Chine] ; Wei Lu [République populaire de Chine] ; Chun-Bao Chen [République populaire de Chine] ; Rong Jiao [République populaire de Chine] ; Ai-Ming Zhang [République populaire de Chine] ; Jin-Tang Wang [République populaire de Chine] ; Xi-Wei Ding [République populaire de Chine] ; Yao-Guang Zeng [République populaire de Chine] ; Li-Ping Cheng [République populaire de Chine] ; Qing-Feng Huang [République populaire de Chine] ; Jiang Wu [République populaire de Chine] ; Xi-Chang Luo [République populaire de Chine] ; Zhu-Jun Wang [République populaire de Chine] ; Yan-Yan Zhong [République populaire de Chine] ; Yan Bai [République populaire de Chine] ; Xiao-Yan Wu [République populaire de Chine] ; Run-Ming Jin [République populaire de Chine] | Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei, China. |
000A66 (2020) |
Ivan Seah [Singapour] ; Rupesh Agrawal [Singapour] | Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals. |
000B26 (2020) |
Piercarlo Sarzi-Puttini [Italie] ; Valeria Giorgi [Italie] ; Silvia Sirotti [Italie] ; Daniela Marotto [Italie] ; Sandro Ardizzone [Italie] ; Giuliano Rizzardini [Italie] ; Spinello Antinori [Italie] ; Massimo Galli [Italie] | COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? |
000B27 (2020) |
Kuldeep Dhama [Inde] ; Khan Sharun [Inde] ; Ruchi Tiwari [Inde] ; Maryam Dadar [Iran] ; Yashpal Singh Malik [Inde] ; Karam Pal Singh [Inde] ; Wanpen Chaicumpa [Thaïlande] | COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. |
000B28 (2020) |
M. Palacios Cruz [Mexique] ; E. Santos ; M A Velázquez Cervantes [Mexique] ; M. Le N Juárez [Mexique] | COVID-19, a worldwide public health emergency. |
000B86 (2020) |
Shahul H. Ebrahim [Mali] ; Ziad A. Memish [États-Unis] | COVID-19 - the role of mass gatherings. |
000C22 (2020) |
Lisi Deng [République populaire de Chine] ; Chunna Li [République populaire de Chine] ; Qi Zeng [République populaire de Chine] ; Xi Liu [République populaire de Chine] ; Xinghua Li [République populaire de Chine] ; Haitang Zhang [République populaire de Chine] ; Zhongsi Hong [République populaire de Chine] ; Jinyu Xia [République populaire de Chine] | Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study. |
000C25 (2020) |
Abdo A. Elfiky | Anti-HCV, nucleotide inhibitors, repurposing against COVID-19 |